According to the World Health Organization, there were 39.9 million people living with HIV worldwide by the end of 2023.

VIDEO | Jamtara: On the HIV blood transfusion row involving thalassemia-infected children, Jharkhand Health Minister Irfan ...

Gilead beats estimates, raises 2025 guidance, driven by strong HIV and liver drug sales and multiple launches planned for ...

A man with HIV accused of raping children was arrested by the Memphis Safe Task Force Thursday, the U.S. Marshals Service ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

Gilead is actively looking for late-stage and de-risked assets for potential deals across various therapeutic spaces, ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Seven, starting on Slide third quarter product sales excluding Victory were $7.1 billion, 4% year over year up Including ...

Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.

Gilead stock reversed higher on smaller losses early Friday as analysts noted encouraging indicators for its newly approved ...

Viral infections trigger inflammation that raises heart disease risk, study finds. Vaccination against COVID, flu and shingles may help prevent cardiovascular complications.

Nearly 40 years after HIV was first identified, the virus continues its devastating march across the globe. Today, 38 million people live with HIV, and each year brings 1.5 million new infections and ...